We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Published results showed patients with shoulder ...
Please provide your email address to receive an email when new articles are posted on . Durect Corporation has announced the FDA approval of Posimir, a post-surgical, non-opioid local analgesic for ...
POSIMIR ® (bupivacaine solution) for infiltration use reduced mean pain over 72 hours after arthroscopic subacromial decompression surgery compared with vehicle control and improved several measures ...
Arthroscopic subacromial decompression surgery does not reduce pain any more than arthroscopy alone in people with shoulder impingement, researchers say. "[T]he findings from our study suggest that ...
In most cases, an arthroscopic subacromial decompression is performed with other separately identifiable procedures. However, if the arthroscopic decompression is the only procedure ...
Mika Paavola, Antti Malmivaara, Simo Taimela, Kari Kanto, Jari Inkinen, Juha Kalske, Ilkka Sinisaari, Vesa Savolainen, Jonas Ranstam, Teppo L N Järvinen and Finnish Shoulder Impingement Arthroscopy ...
Innocoll Pharmaceuticals Limited, a commercial-stage biotechnology company and portfolio business of Gurnet Point Capital, and DURECT Corporation announced the recent commercial launch of Posimir ...
Posimir is a novel formulation of bupivacaine, an amide local anesthetic, designed to be administered directly into the surgical site. Posimir ® (bupivacaine solution) is now available for ...
Dirk-Jan Hofstee, St. Elisabeth Hospital, Tilburg, The Netherlands; dj_hofstee{at}hotmail.com Objectives: The aim of this study was to evaluate whether removing the calcifications in the rotator cuff ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results